series-c-plus
Stage
1
Investors
About
Gamida Cell develops cell therapies for blood cancers and rare blood diseases using its proprietary nicotinamide-based stem cell expansion technology to improve transplantation outcomes for patients lacking suitable donors.
Explore Gamida Cell Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.